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γδ T cells in humans and mice share 
many properties with lymphocytes from 
the innate immune system, expressing, for 
instance, activatory natural killer (NK)-
cell receptors such as NKG2D, inhibitory 
KIR receptors, as well as other cytotoxic 
surface molecules such as tumor necrosis 
factor (TNF)-related apoptosis-inducing 
ligand (TRAIL). Like conventional αβ 
T lymphocytes, γδ T cells express rear-
ranged T-cell receptor (TCRs) compris-
ing two (one γ and one δ) chains, which 
—compared with rearranged and MHC-
restricted αβ TCRs—have a limited range 
of MHC-unrestricted antigenic specifici-
ties. Of note, and again in common with 
NK cells, γδ T cells can express Fcγ 
receptors, most notably FcγRIII (CD16), 
which (at least in humans) is expressed to 
the highest levels by activated cells.1
A relatively new theme in the research 
field dealing with human γδ T lympho-
cytes has emerged following the semi-
nal observation that, upon activation 
by γδ TCR ligation, γδ T cells become 
capable of taking up antigens and medi-
ate professional antigen presentation to 
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naïve αβ T cells.2,3 When compared with 
mature human dendritic cells, γδ T lym-
phocytes express equivalent levels of co-
stimulatory molecules and CCR7, and are 
equally potent at promoting proliferative 
responses in αβ T cells.2
We initially hypothesized that the 
surface expression of CD16 by γδ T cells 
might be indicative of a phagocytic func-
tion, and we showed that human blood 
γδ T cells are indeed capable of taking 
up bacteria and beads, yet only upon 
target opsonisation by IgGs. Following 
the phagocytosis of beads coated with 
an influenza antigen, γδ T cells pro-
cessed and presented the antigen to MHC 
Class II-restricted hybridoma T cells.4
We therefore wondered whether there 
might be a link between the recognition 
of antibody-coated target cells and the 
professional antigen presentation that had 
previously been reported by Moser and 
coworkers,2,3,5 and whether this might have 
implications for oncology, a field in which 
harnessing and regulating the function 
of professional antigen presenting cells 
(APCs) might be exploited therapeutically. 
A precedent for this type of regulation 
is provided by dendritic cells (DCs), for 
which licensing upon the interaction 
with CD40 ligand (CD40L)-expressing 
helper T lymphocytes in the T-cell areas 
of draining lymph nodes is required for 
the presentation of antigens taken up by 
immature DCs at a site of injury, infection 
or cancer.6–8 Interestingly, in the absence 
of a antibody-coated target cells, γδ T cells 
were capable of low levels of cross-pre-
sentation to MHC Class I-restricted αβ 
T cells. Conversely, the presence of opso-
nized target cells was sufficient to achieve 
a degree of cross-presentation by isoprenyl 
pyrophosphate (IPP)-activated human 
circulating γδ T cells that was equiva-
lent to that of mature DCs.9 We have 
termed this phenomenon “licensing” for 
professional APC function by γδ T cells. 
Strikingly, neither antibodies alone, target 
cells alone, nor target cells in the presence 
of non-binding antibodies are capable of 
eliciting this “licensed” state. We demon-
strated licensing using both rituximab and 
CH14.18, two humanized IgG
1
 antibodies 
targeting CD20 and the GD2 ganglioside, 
Following activation, γδ t cells display many properties of lymphocytes from the innate immune system, yet how they 
mediate antigen presentation remains an open conundrum. In humans, circulating γδ t cells that express the Vγ9Vδ2 
t-cell receptor become reversibly licensed for professional antigen presentation only upon interaction with a target cell 
opsonized with IgGs.
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evolution of adaptive immune responses, 
to perform two specialized functions (i.e., 
killing and antigen presentation) in a 
highly regulated manner. Our findings are 
perhaps most exciting from a therapeutic 
perspective, as they imply that monoclo-
nal antibodies used in anticancer therapy 
might be combined with γδ T cells or 
γδ T-cell stimulating factors to modulate 
innate effector functions as well as the gen-
eration of secondary immune responses.
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ability to cross-present antigen is lost 
over a 24 h period. Strikingly, however, 
a licensed and then unlicensed γδ T cell 
can be “re-licensed” by the same anti-
body-opsonized target. We have recently 
observed that the “de-licensing” process 
is associated with the downregulation of 
the co-stimulatory molecules CD80 and 
CD86, while “re-licensing” is associated 
with their re-expression (unpublished 
observations).
Many aspects of the regulation of the 
APC function of γδ T cells remain to 
be investigated. For example, from a sig-
nal transduction perspective, it will be 
interesting to determine whether CD16 
interacts with the γδ TCR at the synapse 
between γδ T cells and target cells and 
whether the rapid and reversible changes 
in co-stimulatory molecule expression 
are driven by cytokine secretion or reflect 
direct transcriptional effects. The APC 
function of γδ T cells from different ana-
tomical sites and bearing different TCRs 
(that exhibit distinct ligand specificities) 
warrants detailed investigation. From an 
even more fundamental research-oriented 
perspective, it will be important to under-
stand whether γδ T cells represent an evo-
lutionarily primitive type of lymphocyte 
or rather one that has emerged after the 
respectively, which are clinically used for 
the treatment of B-cell malignancies and 
neuroblastoma. Human IgG
1
 antibod-
ies efficiently bind FcγRIII (CD16) and, 
accordingly, licensing was abrogated by 
CD16 blocking antibodies.9
A model is therefore emerging suggest-
ing that human γδ T cells are capable of 
operating as professional APCs similar 
to DCs and that—like DC—a specific 
licensing signal is required for them to 
acquire full-blown APC functions (Fig. 1). 
We have also observed that, for acting as 
professional APCs, γδ T cells require the 
engagement of their TCR as well as a cor-
rect cytokine milieu, as demonstrated by 
the fact that γδ T cells acquired APC 
functions only in media conditioned by 
B-cell lymphoblastoid lines (B-LCLs). 
Indeed, we observed the aggregation of 
the γδ TCR in an immune complex at the 
sites of interaction between γδ T cells and 
rituximab-opsonized Daudi cells.9 It will 
be interesting to determine the involve-
ment of CD16-Fc interactions in this 
complex.
Unlike DCs, the licensing of γδ T 
cells is a reversible process. On separating 
licensed circulating γδ T cells from opso-
nized target cells and culturing them in 
the presence of IPP, we found that their 
Figure 1. (A) At the tumor site, circulating γδ t cells bearing the Vγ9Vδ2 t-cell receptor (tCr) become activated and expand as a result of tCr ligation, 
for instance by the isoprenyl pyrophosphate (IPP) phosphoantigen. (B) In the context of an established or nascent immune response, target cells 
become opsonized with antibodies and activated γδ t cells become licensed through IgG/CD16 interactions. (C) this licensing is highly regulated: in 
the absence of continuative interactions with opsonized target cells, γδ t cells rapidly lose their ability to take up and present soluble antigens, such a 
loss being associated with the downregulation of co-stimulatory molecules. hence the APC function of γδ t cells is localized and antigen presentation 
is restricted to tumor-associated antigens, de facto decreasing the risk of autoimmune phenomena.
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